Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Tissue and cell diagnostics market reaches $7.7 billion in 2014

Tissue and cell diagnostics market reaches $7.7 billion in 2014

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Adult survivors of childhood cancer at risk for pituitary hormone deficiencies

Young adult survivors of leukemia and lymphoma report high distress than older survivors

Young adult survivors of leukemia and lymphoma report high distress than older survivors

Researchers generate new reporter system to study bone regeneration potential of embryonic stem cells

Researchers generate new reporter system to study bone regeneration potential of embryonic stem cells

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

Leukemia & Lymphoma Society announces launch of new partnership to empower people with lymphoma

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Researchers identify axitinib as promising candidate to treat drug-resistant leukaemia

Drug similar to Gleevec may help tame some brain cancers

Drug similar to Gleevec may help tame some brain cancers

MSU graduate student discovers critical molecule that helps combat lung infections

MSU graduate student discovers critical molecule that helps combat lung infections

CLL aggressiveness linked to genetic variability

CLL aggressiveness linked to genetic variability

Chemotherapy or immunosuppressive treatment may reactivate HBV

Chemotherapy or immunosuppressive treatment may reactivate HBV

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough therapies for blood cancers may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

Breakthrough blood cancer therapies may provide reasonable value for money spent

New study links cell communication pathway to common brain tumors found in children

New study links cell communication pathway to common brain tumors found in children

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Three Keck Medicine scientists of USC receive $4.3 million from CIRM for stem cell research

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

Anti-viral immune cells could inhibit bone marrow transplant infections caused by CMV

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

Children's Hospital of Philadelphia invited to Obama's announcement of Precision Medicine Initiative

Study identifies genetic basis of drug toxicity in leukemia patients of East Asian ancestry

Study identifies genetic basis of drug toxicity in leukemia patients of East Asian ancestry

Two researchers receive Charles Rodolphe Brupbacher Prize for Cancer Research

Two researchers receive Charles Rodolphe Brupbacher Prize for Cancer Research

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

Damon Runyon Cancer Research Foundation names 15 new Damon Runyon Fellows

FDA’s approval of ibrutinib to treat Waldenstrom's macroglobulinemia receives praises from LLS

FDA’s approval of ibrutinib to treat Waldenstrom's macroglobulinemia receives praises from LLS

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.